CASIF Casi Pharmaceuticals, Inc.

Fundamentals / CIK 0001962738 / USD

Casi Pharmaceuticals, Inc. reported $20.71M in revenue and a net loss of $48.06M for the fiscal year ended December 31, 2025 (down 27.4% year over year), with a 48.6% gross margin and a -217.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CASIF in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$47.59M$23.79M$0-$48.81MFY 2020 Revenue: $15.14MFY 2020 Net Income: -$48.29M2020FY 2021 Revenue: $30.17MFY 2021 Net Income: -$36.65M2021FY 2022 Revenue: $43.11MFY 2022 Net Income: -$41.01M2022FY 2023 Revenue: $33.88MFY 2023 Net Income: -$26.96M2023FY 2024 Revenue: $28.54MFY 2024 Net Income: -$39.26M2024FY 2025 Revenue: $20.71MFY 2025 Net Income: -$48.06M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $20.71M $28.54M $33.88M $43.11M $30.17M $15.14M
Cost of Revenue $10.64M $17.39M $13.83M $15.83M $12.56M $9.51M
Gross Profit $10.08M $11.15M $20.05M $27.28M $17.61M $5.63M
Research & Development $6.31M $8.92M $9.86M $16.00M $14.42M $11.47M
Selling, General & Admin $46.61M $41.44M $41.84M $37.77M $38.41M $27.48M
Operating Income -$45.01M -$39.62M -$25.08M -$34.03M -$41.52M -$52.78M
EBITDA -$43.81M -$38.32M -$22.58M -$32.83M -$41.02M -$52.18M
Interest Expense -- -- -- $0 $2.9K $3.1K
Income Before Tax -$45.87M -$38.07M -$26.29M -$37.43M -$35.84M -$47.51M
Income Tax Expense -- $0 -$81K $1.98M $0 $0
Net Income -$48.06M -$39.26M -$26.96M -$41.01M -$36.65M -$48.29M
Basic EPS -$2.59 -$2.56 -$2.02 -$3.01 -$2.69 -$4.37
Diluted EPS -$2.59 -$2.56 -$2.02 -$3.01 -$2.69 -$4.37
Basic Shares Outstanding 18.5M 15.3M 13.4M 13.6M 13.6M 11.0M
Diluted Shares Outstanding 18.5M 15.3M 13.4M 13.6M 13.6M 11.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for CASIF.

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $5.63M $13.47M $17.08M $47.11M $38.70M
Short-Term Investments -- -- $12.01M $1.46M $9.87M
Cash & Short-Term Investments $5.63M $13.47M $29.09M $48.57M $48.57M
Accounts Receivable, Net $4.09M $15.35M $9.55M $12.97M $9.80M
Inventory $1.60M $5.25M $15.88M $6.14M $1.91M
Total Current Assets $13.46M $39.58M $59.34M $73.42M $61.97M
Property, Plant & Equipment, Net $6.97M $7.87M $9.24M $11.83M $12.71M
Intangible Assets $221K $238K $1.84M $1.06M $12.20M
Long-Term Investments $1.72M $1.91M $1.69M $4.40M $40.13M
Other Non-Current Assets $740K $587K $766K $1.06M $2.18M
Total Non-Current Assets $12.19M $14.10M $15.92M $22.81M $76.33M
Total Assets $25.65M $53.67M $75.27M $96.23M $138.3M
Accounts Payable $1.06M $2.72M $4.44M $3.29M $2.22M
Short-Term Debt $19.19M $18.39M -- -- --
Other Current Liabilities $2.23M $1.33M $1.12M $648K $519K
Total Current Liabilities $49.67M $36.45M $16.73M $17.00M $13.19M
Long-Term Debt -- -- $18.89M -- --
Other Non-Current Liabilities $13.26M $15.37M $15.48M $12.30M $14.32M
Total Non-Current Liabilities $13.26M $15.37M $34.38M $12.30M $17.15M
Total Liabilities $62.93M $51.82M $51.10M $29.30M $30.34M
Total Debt (incl. Leases) $22.24M $22.14M $21.24M $1.34M $2.17M
Common Stock $2.0K $2.0K $1.0K $1.0K $1.0K
Retained Earnings -$748.1M -$700.1M -$660.8M -$637.2M -$605.6M
Accumulated Other Comp. Income -$1.78M -$1.77M -$1.20M -$703K $1.95M
Total Stockholders' Equity -$37.28M $1.85M $24.16M $44.57M $84.50M
Total Equity -$37.28M $1.85M $24.16M $44.57M $84.50M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Cash & Cash Equivalents $5.63M $13.47M $17.08M $47.11M $38.70M
Short-Term Investments -- -- $12.01M $1.46M $9.87M
Cash & Short-Term Investments $5.63M $13.47M $29.09M $48.57M $48.57M
Accounts Receivable, Net $4.09M $15.35M $9.55M $12.97M $9.80M
Inventory $1.60M $5.25M $15.88M $6.14M $1.91M
Total Current Assets $13.46M $39.58M $59.34M $73.42M $61.97M
Property, Plant & Equipment, Net $6.97M $7.87M $9.24M $11.83M $12.71M
Intangible Assets $221K $238K $1.84M $1.06M $12.20M
Long-Term Investments $1.72M $1.91M $1.69M $4.40M $40.13M
Other Non-Current Assets $740K $587K $766K $1.06M $2.18M
Total Non-Current Assets $12.19M $14.10M $15.92M $22.81M $76.33M
Total Assets $25.65M $53.67M $75.27M $96.23M $138.3M
Accounts Payable $1.06M $2.72M $4.44M $3.29M $2.22M
Short-Term Debt $19.19M $18.39M -- -- --
Other Current Liabilities $2.23M $1.33M $1.12M $648K $519K
Total Current Liabilities $49.67M $36.45M $16.73M $17.00M $13.19M
Long-Term Debt -- -- $18.89M -- --
Other Non-Current Liabilities $13.26M $15.37M $15.48M $12.30M $14.32M
Total Non-Current Liabilities $13.26M $15.37M $34.38M $12.30M $17.15M
Total Liabilities $62.93M $51.82M $51.10M $29.30M $30.34M
Total Debt (incl. Leases) $22.24M $22.14M $21.24M $1.34M $2.17M
Common Stock $2.0K $2.0K $1.0K $1.0K $1.0K
Retained Earnings -$748.1M -$700.1M -$660.8M -$637.2M -$605.6M
Accumulated Other Comp. Income -$1.78M -$1.77M -$1.20M -$703K $1.95M
Total Stockholders' Equity -$37.28M $1.85M $24.16M $44.57M $84.50M
Total Equity -$37.28M $1.85M $24.16M $44.57M $84.50M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$48.06M -$39.26M -$26.26M -$40.26M -$35.84M -$47.51M
Depreciation & Amortization $1.20M $1.30M $2.50M $1.20M $500K $600K
Stock-Based Compensation $2.99M $1.31M $7.22M $7.01M $7.77M $7.82M
Change in Receivables $11.25M -$5.79M $3.42M -$3.17M -$5.16M -$3.35M
Change in Inventory $2.50M $5.83M -$9.74M -$4.23M -$551K $3.19M
Change in Payables -$1.66M -$1.72M $1.15M $1.07M $1.49M -$1.54M
Operating Cash Flow -$20.75M -$29.22M -$19.97M -$21.09M -$26.84M -$25.89M
Capital Expenditure -$16K -$223K -$204K -$5.61M -$8.95M -$1.50M
Free Cash Flow -$20.77M -$29.45M -$20.17M -$26.70M -$35.79M -$27.39M
Investing Cash Flow $951K $11.24M -$9.67M $31.16M -$20.69M -$20.72M
Share Repurchases -- -- -$278K -$3.27M -- --
Financing Cash Flow $11.25M $15.43M -$907K -$3.27M $29.64M $47.15M
Net Change in Cash -$7.84M -$3.62M -$30.03M $8.41M -$18.36M $3.44M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for CASIF.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 48.6% 39.1% 59.2% 63.3% 58.4% 37.2%
Operating Margin -217.3% -138.8% -74.0% -78.9% -137.6% -348.6%
Net Profit Margin -232.0% -137.6% -79.6% -95.1% -121.5% -318.9%
Return on Equity (ROE) -- -2120.9% -111.6% -92.0% -43.4% --
Return on Assets (ROA) -187.4% -73.1% -35.8% -42.6% -26.5% --
Current Ratio 0.27x 1.09x 3.55x 4.32x 4.70x --
Quick Ratio 0.24x 0.94x 2.60x 3.96x 4.56x --
Debt to Equity -- 11.96x 0.88x 0.03x 0.03x --
Revenue Growth (YoY) -27.4% -15.8% -21.4% +42.9% +99.2% --
Gross Profit Growth (YoY) -9.6% -44.4% -26.5% +54.9% +212.6% --
5Y Revenue / Share Growth -18.5% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for CASIF.
Source: SEC EDGAR CompanyFacts (CIK 0001962738) · from December 31, 2020 Data through December 31, 2025 · synced Nov 21, 2026, 05:12 UTC · Open in terminal